Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 8, 1997, Pages 503-509

  Delahousse, B ^a   Iochmann, S ^a   Pouplard, C ^a   Fimbel, B ^a   Charbonnier, B ^a   Gruel, Y ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

APC resistance; FV deficiency; FV Leiden

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; DIAGNOSTIC ACCURACY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

EID: 0031455364     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199711000-00004     Document Type: Article

References (22)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
2. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
3. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506.
4. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993.
5. Cadroy Y, Sié P, Boneu B. Frequency of a defective response to activated protein C in patients with a history of venous thrombosis. Blood 1994; 83: 2008-2009.
6. Legnani C, Palareti G, Biagi R, Coccheri S. Activated protein C resistance in deep-vein thrombosis [letter]. Lancet 1994; 343: 541-542.
7. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522.
8. Zoller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524.
9. Jorquera JI, Montoro JM, Fernandez MA, Aznar JA, Aznar J. Modified test for activated protein C resistance [letter]. Lancet 1994; 344: 1162-1163.
10. Trossaert M, Conard J, Horellou MH, Samama MM, Ireland H, Bayston TA, et al. Modified APC resistance assay for patients on oral anticoagulants [letter]. Lancet 1994; 344: 1709.
11. Tosetto F, Rhodeghiero F. Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thromb Haemost 1995; 73: 732-733.
12. Dahlbäck B. Factor V: Q506 and a negative APC-resistance test modified APC-resistance test offers increased sensitivity and specificity for the FV:Q506 allele. Thromb Haemost 1995; 74: 1380-1381.
13. Cadroy Y, Sié P, Alhenc-Gelas M, Aiach M. Evaluation of APC resistance in the plasma of patients with Q506 mutation of Factor V (Factor V Leiden) and treated by oral anticoagulants. Thromb Haemost 1995; 73: 734-735.
14. Greengard JS, Alhenc-Gelas M, Gandrille S, Emmerich J, Aiach M, Griffin J. Pseudo homozygous protein C resistance due to coinheritance of heterozygous factor V-R506Q and type I factor V deficiency associated with thrombosis. Thromb Haemost 1995; 73: 1361 (abstract).
15. Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, et al. 'Pseudo-homozygous' activated protein C resistance due to double heterozygous Factor V defects (Factor V Leiden mutation and type I quantitative Factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thromb Haemost 1996; 75: 422-426.
16. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for FV Arg 506 Gln mutation. Blood Coag Fibrinol 1995; 6: 245-247.
17. Lunghi B, Lacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, et al. Detection of new polymorphic markers in the factor V gene: association with low factor V levels in plasma. Thromb Haemost 1996; 75: 45-48.
18. Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538.
19. Alhenc-Gelas M, Aillaud MF, Bonvarlet MN, Dupuy G, Juhan-Vague I, Aiach M. Specificity of an assay based on a Factor V-depleted plasma in patients carrying the Arg 506 Gln mutation. Thromb Haemost 1996; 75: 976-977.
20. Gouault-Heilmann M, Leroy-Matheron C. Evaluation of a new Chronometric assay for Factor V Leiden-dependent APC resistance. Thromb Res 1997; 85: 357-362.
21. Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa. J Biol Chem 1994; 269: 18735-18738.
22. Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of Factor VIII: influence of the Factor V R506Q mutation. Thromb Haemost 1996; 76: 208-214.